ABL1 and Parkinson disease: Other known c-abl inhibitors currently tested in PD and/or DLB patients include K0706, FB-101, ikT-148009, radotinib, bosutinib and saracatinib (NCT03655236, NCT03996460, NCT04165837, NCT05424276, NCT04350177, NCT04691661, NCT03888222, NCT03661125).